Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | %Female (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
66 | PharmacoVigilance Review | journal | 0.101 Q4 | 2 | 4 | 24 | 10 | 0 | 18 | 0.00 | 2.50 | 33.33 | |
65 | Arzneimitteltherapie | journal | 0.103 Q4 | 6 | 157 | 479 | 814 | 14 | 198 | 0.03 | 5.18 | 55.32 | |
64 | American Journal of Pharmacology and Toxicology (discontinued) | journal | 0.106 Q4 | 24 | 0 | 4 | 0 | 0 | 4 | 0.00 | 0.00 | 0.00 | |
63 | Journal of Medical Marketing | journal | 0.108 Q4 | 20 | 0 | 10 | 0 | 0 | 7 | 0.00 | 0.00 | 0.00 | |
62 | Military Medical Science Letters (Vojenske Zdravotnicke Listy) | journal | 0.108 Q4 | 6 | 28 | 27 | 626 | 7 | 19 | 0.26 | 22.36 | 24.62 | |
61 | Botulinum Journal | journal | 0.114 Q4 | 6 | 0 | 6 | 0 | 1 | 6 | 0.00 | 0.00 | 0.00 | |
60 | Pharmacoeconomics - Spanish Research Articles | journal | 0.114 Q4 | 6 | 0 | 33 | 0 | 3 | 32 | 0.12 | 0.00 | 0.00 | |
59 | Pharmaceuticals Policy and Law | journal | 0.117 Q4 | 11 | 0 | 57 | 0 | 15 | 54 | 0.16 | 0.00 | 0.00 | |
58 | Vitae | journal | 0.117 Q4 | 19 | 12 | 226 | 789 | 41 | 215 | 0.27 | 65.75 | 50.00 | |
57 | HiSTOReLo | journal | 0.125 Q3 | 4 | 24 | 70 | 1088 | 6 | 59 | 0.08 | 45.33 | 35.71 | |
56 | European Pharmaceutical Journal | journal | 0.130 Q3 | 9 | 9 | 41 | 156 | 35 | 40 | 0.85 | 17.33 | 67.65 | |
55 | Natural Volatiles and Essential Oils (discontinued) | journal | 0.133 Q3 | 7 | 17 | 14 | 360 | 6 | 14 | 0.43 | 21.18 | 43.90 | |
54 | Neuropsychopharmacologia Hungarica | journal | 0.136 Q3 | 18 | 20 | 66 | 671 | 15 | 57 | 0.24 | 33.55 | 50.00 | |
53 | Trends in Medical Research (discontinued) | journal | 0.142 Q3 | 11 | 0 | 17 | 0 | 8 | 17 | 0.00 | 0.00 | 0.00 | |
52 | Journal of Pharmacy and Nutrition Sciences (discontinued) | journal | 0.146 Q3 | 14 | 49 | 71 | 1417 | 33 | 70 | 0.52 | 28.92 | 50.00 | |
51 | Journal of Pharmacology and Toxicology (discontinued) | journal | 0.158 Q3 | 22 | 0 | 10 | 0 | 5 | 10 | 0.83 | 0.00 | 0.00 | |
50 | Journal of Research in Pharmacy | journal | 0.159 Q3 | 20 | 113 | 214 | 3739 | 127 | 213 | 0.64 | 33.09 | 56.18 | |
49 | Open Access Journal of Clinical Trials | journal | 0.219 Q3 | 15 | 6 | 19 | 226 | 14 | 19 | 0.85 | 37.67 | 41.67 | |
48 | American Journal of Pharmacy Benefits | journal | 0.227 Q2 | 16 | 0 | 65 | 0 | 39 | 54 | 0.47 | 0.00 | 0.00 | |
47 | Jundishapur Journal of Natural Pharmaceutical Products | journal | 0.228 Q2 | 30 | 57 | 169 | 1741 | 145 | 163 | 0.89 | 30.54 | 37.60 | |
46 | Journal of Pharmaceutical Health Services Research | journal | 0.270 Q2 | 19 | 60 | 130 | 1749 | 96 | 119 | 0.72 | 29.15 | 47.09 | |
45 | Drug Metabolism and Personalized Therapy | journal | 0.282 Q2 | 38 | 24 | 87 | 591 | 119 | 81 | 1.39 | 24.63 | 40.87 | |
44 | Drug Discoveries and Therapeutics | journal | 0.311 Q2 | 31 | 0 | 106 | 0 | 109 | 105 | 0.85 | 0.00 | 0.00 | |
43 | Expert Opinion on Orphan Drugs | journal | 0.311 Q2 | 27 | 54 | 303 | 4491 | 235 | 285 | 0.83 | 83.17 | 44.27 | |
42 | Drug Target Insights | journal | 0.324 Q2 | 16 | 5 | 13 | 209 | 31 | 12 | 2.60 | 41.80 | 61.54 | |
41 | Journal of Negative Results in BioMedicine | journal | 0.357 Q2 | 25 | 0 | 36 | 0 | 35 | 36 | 1.47 | 0.00 | 0.00 | |
40 | Medicinal Chemistry Research | journal | 0.357 Q2 | 59 | 187 | 776 | 7692 | 1455 | 776 | 1.78 | 41.13 | 41.41 | |
39 | Currents in Pharmacy Teaching and Learning | journal | 0.358 Q2 | 31 | 181 | 511 | 4150 | 516 | 469 | 1.05 | 22.93 | 67.46 | |
38 | Journal of Applied Biomedicine | journal | 0.375 Q2 | 38 | 29 | 127 | 1463 | 240 | 126 | 1.91 | 50.45 | 37.42 | |
37 | Molecular and Cellular Toxicology | journal | 0.396 Q2 | 28 | 51 | 148 | 1884 | 243 | 148 | 1.76 | 36.94 | 43.23 | |
36 | Therapeutic Innovation and Regulatory Science | journal | 0.396 Q2 | 51 | 181 | 321 | 4406 | 332 | 276 | 1.01 | 24.34 | 44.09 | |
35 | Value in Health Regional Issues | journal | 0.487 Q1 | 28 | 78 | 177 | 2906 | 217 | 164 | 1.16 | 37.26 | 44.08 | |
34 | Advances in Pharmacological Sciences | journal | 0.531 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
33 | Biomedical Reports | journal | 0.570 Q1 | 38 | 82 | 554 | 2996 | 1114 | 554 | 1.65 | 36.54 | 36.69 | |
32 | Therapeutics and Clinical Risk Management | journal | 0.604 Q1 | 70 | 151 | 668 | 6369 | 1379 | 654 | 2.10 | 42.18 | 34.75 | |
31 | Bioanalysis | journal | 0.606 Q1 | 70 | 207 | 607 | 6083 | 1136 | 536 | 1.73 | 29.39 | 42.99 | |
30 | Journal of Pharmaceutical Policy and Practice | journal | 0.644 Q1 | 32 | 35 | 109 | 1227 | 193 | 96 | 1.49 | 35.06 | 52.90 | |
29 | Journal of Pharmaceutical Investigation | journal | 0.672 Q1 | 39 | 53 | 165 | 2594 | 561 | 163 | 4.07 | 48.94 | 29.33 | |
28 | Marine Drugs | journal | 0.710 | 159 | 709 | 1144 | 42828 | 5389 | 1139 | 4.37 | 60.41 | 44.86 | |
27 | American Journal of Pharmaceutical Education | journal | 0.723 Q1 | 78 | 264 | 557 | 7057 | 1212 | 446 | 1.85 | 26.73 | 60.98 | |
26 | Pharmacogenetics and Genomics | journal | 0.774 | 152 | 30 | 172 | 1278 | 462 | 162 | 2.62 | 42.60 | 40.28 | |
25 | Expert Review of Clinical Pharmacology | journal | 0.792 Q1 | 60 | 114 | 402 | 8383 | 1197 | 359 | 3.39 | 73.54 | 43.32 | |
24 | Patient Preference and Adherence | journal | 0.794 Q1 | 67 | 208 | 727 | 7623 | 1738 | 716 | 2.18 | 36.65 | 51.53 | |
23 | ChemMedChem | journal | 0.895 Q1 | 119 | 195 | 814 | 10943 | 2565 | 786 | 3.13 | 56.12 | 37.21 | |
22 | Pharmacology Research and Perspectives | journal | 0.953 Q1 | 43 | 94 | 228 | 3628 | 577 | 225 | 2.19 | 38.60 | 37.94 | |
21 | Life Sciences | journal | 1.031 Q1 | 191 | 869 | 1480 | 47559 | 5725 | 1477 | 3.80 | 54.73 | 44.18 | |
20 | Drug Metabolism Reviews | journal | 1.119 Q1 | 108 | 32 | 79 | 4301 | 372 | 79 | 4.41 | 134.41 | 43.80 | |
19 | Antibiotics | journal | 1.173 Q1 | 77 | 267 | 186 | 15719 | 790 | 183 | 4.34 | 58.87 | 44.22 | |
18 | Clinical and Translational Science | journal | 1.175 Q1 | 60 | 83 | 182 | 2393 | 570 | 154 | 3.14 | 28.83 | 40.72 | |
17 | Nanotheranostics | journal | 1.271 Q1 | 32 | 24 | 64 | 1469 | 316 | 63 | 4.94 | 61.21 | 44.44 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®